- Home
- XNCR vs INMD Comparison
XNCR vs INMD Comparison
Compare XNCR & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XNCR | INMD |
|---|---|---|
| Founded | 1997 | 2008 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 881.9M | 842.0M |
| IPO Year | 2013 | 2018 |
Fundamental Metrics
Financial Performance| Metric | XNCR | INMD |
|---|---|---|
| Price | $11.34 | $13.99 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 9 | 5 |
| Target Price | ★ $22.33 | $17.33 |
| AVG Volume (30 Days) | 682.9K | ★ 716.6K |
| Earning Date | 05-08-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 65.36 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $125,576,000.00 | N/A |
| Revenue This Year | N/A | $1.74 |
| Revenue Next Year | $4.80 | $3.26 |
| P/E Ratio | ★ N/A | $10.11 |
| Revenue Growth | ★ 13.65 | N/A |
| 52 Week Low | $6.92 | $12.72 |
| 52 Week High | $18.69 | $16.74 |
Technical Indicators
Market Signals| Indicator | XNCR | INMD |
|---|---|---|
| Relative Strength Index (RSI) | 43.34 | 49.24 |
| Support Level | $11.02 | $14.00 |
| Resistance Level | $13.28 | $14.70 |
| Average True Range (ATR) | 0.78 | 0.30 |
| MACD | -0.21 | -0.02 |
| Stochastic Oscillator | 28.45 | 59.92 |
Price Performance
Historical ComparisonAbout XNCR Xencor Inc.
Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.
About INMD InMode Ltd.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.